½ÃÀ庸°í¼­
»óǰÄÚµå
1766078

¼¼°èÀÇ ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå ¿¹Ãø - µ¿¹° À¯Çü, °Ë»ç À¯Çü, »ùÇà À¯Çü, À¯Åë ä³Î, ÃÖÁ¾ »ç¿ëÀÚ, Áö¿ªº° ºÐ¼®(-2032³â)

Pet DNA Testing Market Forecasts to 2032 - Global Analysis By Animal Type (Dogs, Cats, Horses, Birds and Other Animal Types), Test Type, Sample Type, Distribution Channel, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é ¼¼°è ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀåÀº 2025³â 4¾ï 5,610¸¸ ´Þ·¯, ¿¹Ãø ±â°£ µ¿¾È CAGR 12.3%·Î ¼ºÀåÇϰí, 2032³â¿¡´Â 10¾ï 2,730¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. »ç¹°ÀÇ À¯ÀüÀÚ ±¸¼ºÀ» ºÐ¼®ÇÏ´Â µ¥ »ç¿ëµÇ´Â °úÇÐÀûÀÎ ¹æ¹ýÀÔ´Ï´Ù. ÀÐÀ½À¸·Î½á ÁÖÀÎÀº Çൿ °æÇâ, ü°Ý ¿¹Ãø, ƯÁ¤ Áúº´¿¡ ´ëÇÑ ¼ÒÀο¡ ´ëÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹°ÀÇ Àΰ£È­°¡ ÁøÇàµÊ¿¡ µû¶ó DNA °Ë»ç´Â ¹Ý·Áµ¿¹°ÀÇ Äɾî¿Í °Ç°­ÀÇ ÁúÀ» Çâ»ó½ÃŰ´Â µµ±¸·Î¼­ Á¡Á¡ º¸±ÞµÇ°í ÀÖ½À´Ï´Ù.

FEDIAF 2024 º¸°í¼­¿¡ µû¸£¸é ¹Ý·Áµ¿¹° °ü·Ã Á¦Ç° ¹× ¼­ºñ½º ¸ÅÃâÀº 2023³â 274¾ï 5,000¸¸ ´Þ·¯¿¡ À̸£·¶À¸¸ç Àü³â ´ëºñ Å©°Ô Áõ°¡Çß½À´Ï´Ù.

¹Ý·Áµ¿¹° »çÀ°·ü »ó½Â ¹× ÈÞ¸Ó´ÏÁ¦À̼Ç

¹Ý·Áµ¿¹° »çÀ°·üÀÌ Áõ°¡ÇÏ°í ¹Ý·Áµ¿¹°ÀÇ Àΰ£È­ Ãß¼¼°¡ ³ô¾ÆÁü¿¡ µû¶ó ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀåÀ» Å©°Ô °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ¹Ý·Áµ¿¹° ÁÖÀεéÀº ¹Ý·Áµ¿¹°ÀÇ Ç÷Åë, ǰÁ¾, °Ç°­ ¼ºÇâ, Ư¼º¿¡ ´ëÇØ Á¡Á¡ ´õ ±Ã±ÝÇØÇϰí ÀÖÀ¸¸ç, ÀÌ´Â DNA °Ë»ç ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

Á¤È®¼º°ú ½Å·Ú¼º¿¡ ´ëÇÑ ¿ì·Á

Á¤È®¼º°ú ½Å·Ú¼º¿¡ ´ëÇÑ ¿ì·Á´Â ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀåÀÇ ¼ºÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌĨ´Ï´Ù. ´Ù¸¥ °Ë»ç¿¡¼­ »óÃæµÇ´Â Á¤º¸°¡ ¾ò¾îÁö¸é °Ç°­ »óÅÂ¿Í Ç°Á¾¿¡ ´ëÇÑ º¸°í Ÿ´ç¼ºÀ» ÀǽÉÇÒ ¼ö ÀÖ½À´Ï´Ù.

°Ç°­°ú À£ºù¿¡ ´ëÇÑ ÀÇ½Ä ÁõÁø

¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀåÀº ¹Ý·Áµ¿¹° ÁÖÀÎµé »çÀÌ¿¡¼­ °Ç°­°ú À£´Ï½º¿¡ ´ëÇÑ ÀǽÄÀÌ ³ô¾ÆÁö°í ÀÖ´Â °ÍÀÌ È£ÀÇÀûÀ¸·Î ¿òÁ÷À̰í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °ü½É»çÀÇ º¯È­´Â Àå±âÀûÀÎ °Ç°­°ú ¿¹¹æ ÀǷḦ º¸ÀåÇϱâ À§ÇØ DNA °Ë»ç ŰƮÀÇ »ç¿ëÀ» ÃËÁøÇÕ´Ï´Ù.

³ôÀº ºñ¿ë°ú Á¦ÇÑµÈ Á¢±Ù¼º

¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀåÀÇ È®ÀåÀ» ¹æÇØÇÏ´Â °ÍÀº ³ôÀº ºñ¿ë°ú Á¦ÇÑµÈ Á¢±Ù¼ºÀÔ´Ï´Ù. ¼ÒºñÀÚ Á¢±ÙÀº ¼Ò¿ÜµÈ Áö¿ªÀ̳ª ³óÃÌ Áö¿ª¿¡¼­ÀÇ Á¦ÇÑµÈ °¡¿ë¼ºÀ¸·Î ÀÎÇØ Á¦Çѵ˴ϴÙ.

COVID-19ÀÇ ¿µÇâ

COVID-19ÀÇ À¯ÇàÀº ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå¿¡ ´Ù¾çÇÑ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. Ãʱâ È¥¶õÀº °ø±Þ¸Á¿¡ ¿µÇâÀ» ¹ÌÄ¡°í, ÇÊ¿ä ¾ø´Â ¼öÀÇÇÐ ¼­ºñ½º¸¦ Áö¿¬½ÃÄ×Áö¸¸, Æó¼â ±â°£ µ¿¾È ¹Ý·Áµ¿¹° ÀÔ¾ç Áõ°¡´Â DNA °Ë»ç ŰƮ¸¦ Æ÷ÇÔÇÑ °¡Á¤¿¡¼­ ¹Ý·Áµ¿¹° °ü¸® ¼Ö·ç¼Ç ¼ö¿ä¸¦ Å©°Ô ²ø¾î ¿Ã·È½À´Ï´Ù. À¯Çà ±â°£ µ¿¾È ¹Ý·Áµ¿¹°ÀÇ °Ç°­°ú À£ºù¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¼ÒºñÀÚÀÇ °ü½ÉÀ» ´õ¿í ºÎÃß°Ü ¹Ý·Áµ¿¹° À¯ÀüÀÚ °Ë»ç Á¦°ø¾÷üÀÇ ÀÎÁöµµ Çâ»ó°ú ¼ºÀå ±âȸ·Î À̾îÁ³½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È ǰÁ¾ ½Äº° ºÎ¹®ÀÌ ÃÖ´ë°¡ µÉ Àü¸Á

¹Ý·Áµ¿¹° ÁÖÀÎÀÇ È£±â½É Áõ°¡¿Í °³ÀÎ °ü¸® ¼ö¿ä·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È ǰÁ¾ ½Äº° ºÎ¹®ÀÌ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¹Ý·Áµ¿¹°ÀÇ Ç°Á¾À» È®ÀÎÇÏ¸é ¹Ý·Áµ¿¹°¿¡ ¸Â´Â ¿µ¾ç, ÈÆ·Ã ¹× °Ç°­ °ü¸®°¡ °¡´ÉÇÏ¸ç ¹Ý·Áµ¿¹°ÀÇ Çູµµ°¡ ³ô¾ÆÁý´Ï´Ù. ÀÌ ºÎ¹®Àº ¶ÇÇÑ º¸È£ ½Ã¼³ÀÌ ÁÖÀÎ Èĺ¸¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇÔÀ¸·Î½á ÀÔ¾çÀ» Áö¿øÇÕ´Ï´Ù. ¹Ý·Áµ¿¹°ÀÇ Àΰ£È­ µ¿ÇâÀÌ °è¼ÓµÇ°í ÀÖ´Â °¡¿îµ¥, °ßÁ¾ °íÀ¯ÀÇ Æ¯Â¡À» ÀÌÇØÇÏ°í ½Í´Ù´Â ¿ä¸ÁÀÌ DNA °Ë»ç ¼ö¿ä¸¦ ºÎÃß°Ü, °ßÁ¾ ½Äº°ÀÌ ½ÃÀåÀÇ Áß½ÉÀûÀÎ ¼öÀÍÀ» ³º´Â ¿ä¼Ò°¡ µÇ°í ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È CAGRÀÌ °¡Àå ³ôÀ» °ÍÀ¸·Î ¿¹»óµÇ´Â ±¸°­ ¸éºÀ(buccal swab) ºÎ¹®

¿¹Ãø ±â°£ µ¿¾È ±¸°­ ¸éºÀ(buccal swab) ºÎ¹®Àº ´Ü¼øÇÏ°í ºñ ħ½ÀÀûÀÌ¸ç ¹Ý·Áµ¿¹° ģȭÀûÀÎ »ùÇøµ ±â¼ú·Î ÀÎÇØ °¡Àå ³ôÀº ¼ºÀå·üÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±¸°­ ¸éºÀÀº Áý¿¡¼­ °íÅë ¾øÀÌ DNA¸¦ äÃëÇÒ ¼ö Àֱ⠶§¹®¿¡ ¹Ý·Áµ¿¹° ÁÖÀο¡°Ô ¼±È£µÇ¾î ÁÖÀΰú ¹Ý·Áµ¿¹° ¸ðµÎÀÇ ½ºÆ®·¹½º¸¦ ÁÙÀÏ ¼ö ÀÖ½À´Ï´Ù. ±× ÆíÀǼº ¶§¹®¿¡ °í°´À̳ª µ¿¹° º´¿ø¿¡¼­ÀÇ Ã¤Åõµ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, »´ ½º¿Íºê´Â Á¤È®ÇÑ À¯Àü ¹°ÁúÀÇ Ã¤Ã븦 º¸ÀåÇϱ⠶§¹®¿¡ °Ë»ç °á°úÀÇ ½Å·Ú¼ºÀÌ Çâ»óµÇ°í ¹Ý·Áµ¿¹° DNA °Ë»ç ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.

ÃÖ´ë Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª

¿¹Ãø ±â°£ µ¿¾È ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¹Ý·Áµ¿¹° »çÀ°·ü Áõ°¡, °¡Ã³ºÐ ¼Òµæ Áõ°¡, ¹Ý·Áµ¿¹°ÀÇ °Ç°­°ú À¯ÀüÇп¡ ´ëÇÑ ÀÇ½Ä Áõ°¡·Î ÀÎÇØ ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. Á¶»ó ÃßÀûÀ» À§ÇÑ DNA °Ë»ç¿Í °°Àº Áøº¸µÈ Áø´Ü¿¡ ´ëÇÑ ÅõÀÚ¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼öÀÇÇÐ ÀÎÇÁ¶óÀÇ È®´ë¿Í Çõ½ÅÀûÀÎ °Ë»ç ŰƮÀÇ °¡¿ë¼ºÀÌ ½ÃÀå ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖÀ¸¸ç, ¾Æ½Ã¾ÆÅÂÆò¾çÀº ¼¼°è Á¤¼¼ÀÇ ÁÖ¿ä ¼ºÀå Áö¿ªÀÌ µÇ°í ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª

¿¹Ãø ±â°£ µ¿¾È ºÏ¹Ì°¡ °¡Àå ³ôÀº CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À̰ÍÀº ¹Ý·Áµ¿¹°À» Ű¿ì´Â »ç¶÷ÀÌ Áõ°¡ÇÏ°í µ¿¹°ÀÇ À¯ÀüÇаú °Ç°­¿¡ ´ëÇÑ Áö½ÄÀÌ ±í¾îÁö±â ¶§¹®ÀÔ´Ï´Ù. ³ôÀº °¡Ã³ºÐ ¼Òµæ°ú Á¤±³ÇÑ ¼öÀÇÇÐÀû ÀÎÇÁ¶ó°¡ ÀÌ·¯ÇÑ Áø´ÜÀÇ ÀÌ¿ëÀ» µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¹«·á ¸ÂÃãÇü ¼­ºñ½º

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½ ¹«·á ¸ÂÃã¼³Á¤ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ±â¾÷ ÇÁ·ÎÆÄÀÏ
    • Ãß°¡ ½ÃÀå ÁøÃâ±â¾÷ÀÇ Á¾ÇÕÀû ÇÁ·ÎÆÄÀϸµ(3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ÀÇ SWOT ºÐ¼®(3°³»ç±îÁö)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ ÀÀÇÑ ÁÖ¿ä±¹ ½ÃÀå ÃßÁ¤, ¿¹Ãø, CAGR(ÁÖ : Ÿ´ç¼º È®Àο¡ µû¸§)
  • °æÀï º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû Á¸Àç, Àü·«Àû Á¦ÈÞ¸¦ ÅëÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù
  • Á¶»ç ÀÚ·á
    • 1Â÷ Á¶»ç ÀÚ·á
    • 2Â÷ Á¶»ç ÀÚ·á
    • ÀüÁ¦Á¶°Ç

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼Ò°³
  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • ÃÖÁ¾ »ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ±â¾÷ÀÇ Çù»ó·Â
  • ±¸¸ÅÀÚÀÇ Çù»ó·Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô Âü°¡¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷°£ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå : µ¿¹° À¯Çüº°

  • ¼Ò°³
  • °³
  • °í¾çÀÌ
  • ¸»
  • »õ
  • ±âŸ µ¿¹° À¯Çü

Á¦6Àå ¼¼°èÀÇ ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå : °Ë»ç À¯Çüº°

  • ¼Ò°³
  • ǰÁ¾ ½Äº°
  • À¯Àü¼º Áúȯ°ú °Ç°­ À§Çè
  • Á¶»ó°ú °èº¸
  • Çൿ Ư¼º

Á¦7Àå ¼¼°èÀÇ ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå : »ùÇà À¯Çüº°

  • ¼Ò°³
  • »´ ½º¿Íºê
  • Ç÷¾×
  • ±âŸ Á¶Á÷ »ùÇÃ

Á¦8Àå ¼¼°èÀÇ ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå : À¯Åë ä³Îº°

  • ¼Ò°³
  • ¿Â¶óÀÎ Ç÷§Æû
  • ¼öÀÇ»ç Ŭ¸®´Ð
  • ¹Ý·Áµ¿¹° ¼ó
  • ¼ÒºñÀÚ Á÷Á¢ ÆÇ¸Å(DTC)

Á¦9Àå ¼¼°èÀÇ ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼Ò°³
  • ¹Ý·Áµ¿¹° ÁÖÀÎ
  • ºê¸®´õ
  • ¼öÀÇ»ç
  • ¿¬±¸±â°ü
  • ±âŸ

Á¦10Àå ¼¼°èÀÇ ¹Ý·Áµ¿¹° DNA °Ë»ç ½ÃÀå : Áö¿ªº°

  • ¼Ò°³
  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦11Àå ÁÖ¿ä °³¹ß

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, ÇÕÀÛÅõÀÚ
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦12Àå ±â¾÷ ÇÁ·ÎÆÄÀϸµ

  • Mars Incorporated
  • Zoetis Inc.
  • Embark Veterinary Inc.
  • Neogen Corporation
  • Macrogen Inc.
  • EasyDNA
  • Orivet Genetic Pet Care LLC
  • DNA MY DOG Inc.
  • Animal Genetics Inc.
  • GenSol Diagnostics LLC
  • FamilyTreeDNA
  • AncestryDNA Inc.
  • Urban Animal Inc.
  • Control Genetics
  • OptiGen
  • VetGen
  • HealthGene
  • Paw Print Genetics
  • Canine HealthCheck
SHW 25.07.16

According to Stratistics MRC, the Global Pet DNA Testing Market is accounted for $456.1 million in 2025 and is expected to reach $1027.3 million by 2032 growing at a CAGR of 12.3% during the forecast period. Pet DNA testing is a scientific method used to analyze the genetic makeup of animals, primarily dogs and cats, through a sample of saliva or cheek swab. This test helps identify the breed composition, ancestry, inherited traits, and potential genetic health risks of a pet. By decoding the pet's DNA, owners can gain insights into behavior tendencies, size predictions, and predispositions to certain diseases. Veterinarians and pet owners use this information to make informed decisions about healthcare, nutrition, and training. As pet humanization rises, DNA testing has become an increasingly popular tool for improving the quality of pet care and well-being.

According to the FEDIAF 2024 report, pet-related products and services sales reached USD 27.45 billion in 2023, a significant rise over the prior year.

Market Dynamics:

Driver:

Rising Pet Ownership & Humanization

Rising pet ownership and the growing trend of pet humanization are significantly driving the Pet DNA Testing Market. As more individuals consider pets as family members, they are increasingly investing in advanced healthcare solutions, including genetic testing, to ensure their pets' well-being. Pet owners are becoming more curious about their pets' ancestry, breed, health predispositions, and traits, fueling demand for DNA testing services. This emotional and preventive healthcare connection is pushing market players to innovate and expand their offerings, boosting market growth.

Restraint:

Accuracy & Reliability Concerns

Accuracy and reliability concerns are negatively impacting the growth of the Pet DNA Testing Market. Inconsistent results and lack of standardization among different testing providers reduce consumer confidence and limit adoption. Pet owners may question the validity of health or breed reports, especially when different tests yield conflicting information. These doubts hinder widespread trust and slow market expansion, especially among veterinarians and breeders who rely on precise genetic insights.

Opportunity:

Growing Health & Wellness Awareness

The Pet DNA Testing Market is being driven favourably by increasing health and wellness awareness among pet owners. People are becoming more interested in knowing their pets' genetic composition in order to proactively manage health concerns, nutritional requirements, and breed-specific diseases as they treat pets more like members of the family. This change in perspective promotes the use of DNA testing kits to guarantee long-term health and preventive care. The trend is also in line with the growing need for individualized pet care solutions, which is further accelerating market expansion.

Threat:

High Costs & Limited Accessibility

High costs and limited accessibility stymie the expansion of the Pet DNA Testing Market. Many pet owners, particularly those in underdeveloped nations, cannot afford the cost of testing kits and services. Additionally, consumer access is restricted by limited availability in underserved or rural locations. Even while interest in pet health and genetic insights is growing, these constraints taken together limit market penetration, reducing demand and slowing adoption.

Covid-19 Impact

The Covid-19 pandemic had a mixed impact on the Pet DNA Testing Market. While initial disruptions affected supply chains and delayed non-essential veterinary services, the rise in pet adoptions during lockdowns significantly boosted demand for at-home pet care solutions, including DNA testing kits. Increased focus on pet health and wellness during the pandemic further fueled consumer interest, leading to greater awareness and growth opportunities for pet genetic testing providers.

The breed identification segment is expected to be the largest during the forecast period

The breed identification segment is expected to account for the largest market share during the forecast period, due to rising pet owner curiosity and demand for personalized care. Identifying a pet's breed enables tailored nutrition, training, and health management, enhancing pet well-being. This segment also supports adoption efforts by helping shelters provide potential owners with more detailed information. As pet humanization trends continue, the desire for understanding breed-specific traits fuels the demand for DNA testing, making breed identification a central revenue-generating component of the market.

The buccal swab segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the buccal swab segment is predicted to witness the highest growth rate, because of its simple, non-invasive, and pet-friendly sampling technique. Buccal swabs are preferred by pet owners because they make it possible to collect DNA at home painlessly, which lessens stress for both owners and pets. Customers and veterinary clinics have adopted it more frequently as a result of its convenience. Furthermore, buccal swabs guarantee precise genetic material collection, which improves test result reliability and increases demand for pet DNA testing services.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share owing to rising pet adoption rates, increasing disposable income, and growing awareness of pet health and genetics. Urbanization and the humanization of pets are encouraging owners to invest in advanced diagnostics like DNA testing for breed identification, health screening, and ancestry tracking. Additionally, expanding veterinary infrastructure and the availability of innovative testing kits are driving market demand, making Asia Pacific a key growth region in the global landscape.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR, because more people keep pets and are more knowledgeable about the genetics and health of animals. Customers are taking the initiative to learn more about the breed, health hazards, and ancestry of their pets. High disposable incomes and sophisticated veterinary infrastructure encourage the use of these diagnostics. Additionally, as pets become more humanized, there is a greater need for individualized pet care products, which makes North America a major driver of the market's growth.

Key players in the market

Some of the key players profiled in the Pet DNA Testing Market include Mars Incorporated, Zoetis Inc., Embark Veterinary Inc., Neogen Corporation, Macrogen Inc., EasyDNA, Orivet Genetic Pet Care LLC, DNA MY DOG Inc., Animal Genetics Inc., GenSol Diagnostics LLC, FamilyTreeDNA, AncestryDNA Inc., Urban Animal Inc., Control Genetics, OptiGen, VetGen, HealthGene, Paw Print Genetics and Canine HealthCheck.

Key Developments:

In August 2024, Mars, Incorporated and Kellanova announced that they have entered into a definitive agreement under which Mars has agreed to acquire Kellanova for $83.50 per share in cash, for a total consideration of $35.9 billion, including assumed net leverage.

In October 2022, Accenture is working with Mars, the global leader in confectionary, food, and pet care products and services, to transform and modernize its global manufacturing operations with artificial intelligence (AI), cloud, edge technology and digital twins.

Animal Types Covered:

  • Dogs
  • Cats
  • Horses
  • Birds
  • Other Animal Types

Test Types Covered:

  • Breed Identification
  • Genetic Diseases & Health Risks
  • Ancestry & Lineage
  • Behavioral Traits

Sample Types Covered:

  • Buccal Swab
  • Blood
  • Other Tissue Samples

Distribution Channels Covered:

  • Online Platforms
  • Veterinary Clinics
  • Pet Stores
  • Direct to Consumer (DTC)

End Users Covered:

  • Pet Owners
  • Breeders
  • Veterinarians
  • Research Institutions
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Pet DNA Testing Market, By Animal Type

  • 5.1 Introduction
  • 5.2 Dogs
  • 5.3 Cats
  • 5.4 Horses
  • 5.5 Birds
  • 5.6 Other Animal Types

6 Global Pet DNA Testing Market, By Test Type

  • 6.1 Introduction
  • 6.2 Breed Identification
  • 6.3 Genetic Diseases & Health Risks
  • 6.4 Ancestry & Lineage
  • 6.5 Behavioral Traits

7 Global Pet DNA Testing Market, By Sample Type

  • 7.1 Introduction
  • 7.2 Buccal Swab
  • 7.3 Blood
  • 7.4 Other Tissue Samples

8 Global Pet DNA Testing Market, By Distribution Channel

  • 8.1 Introduction
  • 8.2 Online Platforms
  • 8.3 Veterinary Clinics
  • 8.4 Pet Stores
  • 8.5 Direct to Consumer (DTC)

9 Global Pet DNA Testing Market, By End User

  • 9.1 Introduction
  • 9.2 Pet Owners
  • 9.3 Breeders
  • 9.4 Veterinarians
  • 9.5 Research Institutions
  • 9.6 Other End Users

10 Global Pet DNA Testing Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Mars Incorporated
  • 12.2 Zoetis Inc.
  • 12.3 Embark Veterinary Inc.
  • 12.4 Neogen Corporation
  • 12.5 Macrogen Inc.
  • 12.6 EasyDNA
  • 12.7 Orivet Genetic Pet Care LLC
  • 12.8 DNA MY DOG Inc.
  • 12.9 Animal Genetics Inc.
  • 12.10 GenSol Diagnostics LLC
  • 12.11 FamilyTreeDNA
  • 12.12 AncestryDNA Inc.
  • 12.13 Urban Animal Inc.
  • 12.14 Control Genetics
  • 12.15 OptiGen
  • 12.16 VetGen
  • 12.17 HealthGene
  • 12.18 Paw Print Genetics
  • 12.19 Canine HealthCheck
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦